GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000078561.3 | early B cell factor 1 |
Ebf1
|
ENSMUSG00000057098.8 | early B cell factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf1 | mm10_v2_chr11_+_44617310_44617336 | 0.78 | 2.5e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_84980458 | 15.60 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chrX_-_7967817 | 10.46 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr17_+_48359891 | 10.41 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr16_-_16863975 | 9.73 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr11_+_117797660 | 9.41 |
ENSMUST00000106331.1
|
6030468B19Rik
|
RIKEN cDNA 6030468B19 gene |
chr9_-_109849440 | 9.21 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr8_-_122460666 | 8.83 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr2_+_131186942 | 8.70 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr11_-_102365111 | 8.46 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr19_+_7268296 | 8.35 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr16_-_16863817 | 7.58 |
ENSMUST00000124890.1
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr6_+_86628174 | 7.20 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr4_+_134864536 | 7.00 |
ENSMUST00000030627.7
|
Rhd
|
Rh blood group, D antigen |
chr16_+_36156801 | 6.69 |
ENSMUST00000079184.4
|
Stfa2l1
|
stefin A2 like 1 |
chr17_+_25298389 | 6.29 |
ENSMUST00000037453.2
|
Prss34
|
protease, serine, 34 |
chr1_-_88205674 | 5.82 |
ENSMUST00000119972.2
|
Dnajb3
|
DnaJ (Hsp40) homolog, subfamily B, member 3 |
chr15_+_80623499 | 5.75 |
ENSMUST00000043149.7
|
Grap2
|
GRB2-related adaptor protein 2 |
chr12_-_4874341 | 5.73 |
ENSMUST00000137337.1
ENSMUST00000045921.7 |
Mfsd2b
|
major facilitator superfamily domain containing 2B |
chr10_+_79879614 | 5.68 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr14_-_51057242 | 5.50 |
ENSMUST00000089798.2
|
Rnase12
|
ribonuclease, RNase A family, 12 (non-active) |
chr11_-_102101310 | 5.42 |
ENSMUST00000170554.2
ENSMUST00000017460.5 |
Ppy
|
pancreatic polypeptide |
chr6_+_86078070 | 5.39 |
ENSMUST00000032069.5
|
Add2
|
adducin 2 (beta) |
chr14_-_60086832 | 5.37 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr8_-_111691002 | 5.28 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr7_+_19411086 | 5.16 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
chr16_+_17980565 | 5.09 |
ENSMUST00000075371.3
|
Vpreb2
|
pre-B lymphocyte gene 2 |
chr17_+_28769307 | 5.02 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr11_+_115877497 | 5.00 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
chr7_+_24370255 | 4.91 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr8_+_71597648 | 4.91 |
ENSMUST00000143662.1
|
Fam129c
|
family with sequence similarity 129, member C |
chrX_+_136033367 | 4.88 |
ENSMUST00000057625.2
|
Arxes1
|
adipocyte-related X-chromosome expressed sequence 1 |
chr12_+_109452833 | 4.88 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr18_-_35649349 | 4.85 |
ENSMUST00000025211.4
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr16_-_96443595 | 4.70 |
ENSMUST00000113773.1
ENSMUST00000000161.7 |
Itgb2l
|
integrin beta 2-like |
chr14_-_20269162 | 4.70 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr6_-_116461024 | 4.61 |
ENSMUST00000164547.1
ENSMUST00000170186.1 |
Alox5
|
arachidonate 5-lipoxygenase |
chr11_+_95010277 | 4.55 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr7_-_142679533 | 4.54 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr8_+_23139030 | 4.54 |
ENSMUST00000121075.1
|
Ank1
|
ankyrin 1, erythroid |
chr6_-_115762346 | 4.50 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr7_+_79660196 | 4.42 |
ENSMUST00000035977.7
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr8_+_23139064 | 4.41 |
ENSMUST00000033947.8
|
Ank1
|
ankyrin 1, erythroid |
chrX_-_136215443 | 4.40 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr7_+_96211656 | 4.39 |
ENSMUST00000107165.1
|
Tenm4
|
teneurin transmembrane protein 4 |
chr11_+_115154139 | 4.37 |
ENSMUST00000021076.5
|
Rab37
|
RAB37, member of RAS oncogene family |
chr6_+_41354105 | 4.22 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr7_+_24777172 | 4.21 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr6_-_69284319 | 4.17 |
ENSMUST00000103349.1
|
Igkv4-69
|
immunoglobulin kappa variable 4-69 |
chr5_-_134946917 | 4.17 |
ENSMUST00000051401.2
|
Cldn4
|
claudin 4 |
chr6_+_30639218 | 4.15 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr2_+_173022360 | 4.12 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chrX_+_135993820 | 4.11 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr17_+_48232755 | 4.11 |
ENSMUST00000113251.3
ENSMUST00000048782.6 |
Trem1
|
triggering receptor expressed on myeloid cells 1 |
chr2_-_28084877 | 4.11 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr9_+_65101453 | 4.07 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chr5_+_137288273 | 4.05 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr6_+_34412334 | 4.03 |
ENSMUST00000007449.8
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr12_-_109068173 | 4.01 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr14_-_70630149 | 3.97 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr1_+_135840857 | 3.90 |
ENSMUST00000179863.1
ENSMUST00000112086.2 ENSMUST00000112087.2 ENSMUST00000112085.2 ENSMUST00000178854.1 ENSMUST00000027671.5 |
Tnnt2
|
troponin T2, cardiac |
chr7_-_100855403 | 3.90 |
ENSMUST00000156855.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr5_-_145469723 | 3.85 |
ENSMUST00000031633.4
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr10_+_75566257 | 3.81 |
ENSMUST00000129232.1
ENSMUST00000143792.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chrX_-_52613936 | 3.79 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr11_+_78346666 | 3.77 |
ENSMUST00000100755.3
|
Unc119
|
unc-119 homolog (C. elegans) |
chr8_+_83955507 | 3.71 |
ENSMUST00000005607.8
|
Asf1b
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
chr11_+_58917889 | 3.71 |
ENSMUST00000069941.6
|
Btnl10
|
butyrophilin-like 10 |
chr7_+_142442330 | 3.70 |
ENSMUST00000149529.1
|
Tnni2
|
troponin I, skeletal, fast 2 |
chr2_+_25372315 | 3.66 |
ENSMUST00000028329.6
ENSMUST00000114293.2 ENSMUST00000100323.2 |
Sapcd2
|
suppressor APC domain containing 2 |
chr10_+_79881023 | 3.64 |
ENSMUST00000166201.1
|
Prtn3
|
proteinase 3 |
chrX_+_136138996 | 3.62 |
ENSMUST00000116527.1
|
Bex4
|
brain expressed gene 4 |
chr6_-_41704339 | 3.60 |
ENSMUST00000031899.8
|
Kel
|
Kell blood group |
chr11_+_115899943 | 3.60 |
ENSMUST00000152171.1
|
Smim5
|
small integral membrane protein 5 |
chr13_-_53286052 | 3.59 |
ENSMUST00000021918.8
|
Ror2
|
receptor tyrosine kinase-like orphan receptor 2 |
chr10_-_128401218 | 3.59 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr15_-_55090422 | 3.58 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr2_-_163918683 | 3.52 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr15_+_75156693 | 3.51 |
ENSMUST00000023246.3
|
Ly6g
|
lymphocyte antigen 6 complex, locus G |
chr19_+_52264323 | 3.51 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr3_+_108364882 | 3.49 |
ENSMUST00000090563.5
|
Mybphl
|
myosin binding protein H-like |
chr14_-_60087347 | 3.48 |
ENSMUST00000149414.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr11_+_7197780 | 3.40 |
ENSMUST00000020704.7
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr7_-_142661858 | 3.40 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr11_+_87793722 | 3.40 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr7_-_142699510 | 3.39 |
ENSMUST00000105934.1
|
Ins2
|
insulin II |
chr8_-_85365317 | 3.36 |
ENSMUST00000034133.7
|
Mylk3
|
myosin light chain kinase 3 |
chr11_-_87875524 | 3.36 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr2_-_24763047 | 3.35 |
ENSMUST00000100348.3
ENSMUST00000041342.5 ENSMUST00000114447.1 ENSMUST00000102939.2 ENSMUST00000070864.7 |
Cacna1b
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr9_+_110857958 | 3.26 |
ENSMUST00000051097.1
|
Prss50
|
protease, serine, 50 |
chr2_+_130295148 | 3.23 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr19_-_10203880 | 3.21 |
ENSMUST00000142241.1
ENSMUST00000116542.2 ENSMUST00000025651.5 ENSMUST00000156291.1 |
Fen1
|
flap structure specific endonuclease 1 |
chr7_+_141061274 | 3.20 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr11_-_116076986 | 3.19 |
ENSMUST00000153408.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr6_-_116461151 | 3.14 |
ENSMUST00000026795.6
|
Alox5
|
arachidonate 5-lipoxygenase |
chr7_+_100493337 | 3.14 |
ENSMUST00000126534.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_+_115900125 | 3.14 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr10_-_79788924 | 3.14 |
ENSMUST00000020573.6
|
Prss57
|
protease, serine 57 |
chr17_+_36869567 | 3.13 |
ENSMUST00000060524.9
|
Trim10
|
tripartite motif-containing 10 |
chr16_+_32756336 | 3.13 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr10_+_20347788 | 3.12 |
ENSMUST00000169712.1
|
Mtfr2
|
mitochondrial fission regulator 2 |
chr8_-_85365341 | 3.12 |
ENSMUST00000121972.1
|
Mylk3
|
myosin light chain kinase 3 |
chr4_+_130308595 | 3.10 |
ENSMUST00000070532.7
|
Fabp3
|
fatty acid binding protein 3, muscle and heart |
chr17_+_34597852 | 3.09 |
ENSMUST00000174496.2
ENSMUST00000015596.3 ENSMUST00000173992.1 |
Ager
|
advanced glycosylation end product-specific receptor |
chr16_-_16869255 | 3.09 |
ENSMUST00000075017.4
|
Vpreb1
|
pre-B lymphocyte gene 1 |
chr4_+_115057683 | 3.06 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr7_-_45238794 | 3.06 |
ENSMUST00000098461.1
ENSMUST00000107797.1 |
Cd37
|
CD37 antigen |
chr11_-_97996171 | 3.03 |
ENSMUST00000042971.9
|
Arl5c
|
ADP-ribosylation factor-like 5C |
chr5_-_43981757 | 3.03 |
ENSMUST00000061299.7
|
Fgfbp1
|
fibroblast growth factor binding protein 1 |
chr10_+_75943020 | 3.02 |
ENSMUST00000121151.1
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr1_+_134182150 | 3.01 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr10_-_85102487 | 3.01 |
ENSMUST00000059383.6
|
Fhl4
|
four and a half LIM domains 4 |
chr1_+_75400070 | 3.00 |
ENSMUST00000113589.1
|
Speg
|
SPEG complex locus |
chrX_-_52613913 | 2.99 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr4_+_46039202 | 2.98 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr11_+_62575981 | 2.97 |
ENSMUST00000102643.1
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr2_+_13573927 | 2.96 |
ENSMUST00000141365.1
ENSMUST00000028062.2 |
Vim
|
vimentin |
chr5_+_136967859 | 2.94 |
ENSMUST00000001790.5
|
Cldn15
|
claudin 15 |
chr13_-_113100971 | 2.92 |
ENSMUST00000023897.5
|
Gzma
|
granzyme A |
chr8_+_57455898 | 2.92 |
ENSMUST00000034023.3
|
Scrg1
|
scrapie responsive gene 1 |
chr1_-_128592284 | 2.90 |
ENSMUST00000052172.6
ENSMUST00000142893.1 |
Cxcr4
|
chemokine (C-X-C motif) receptor 4 |
chr2_+_128591205 | 2.89 |
ENSMUST00000155430.1
|
Gm355
|
predicted gene 355 |
chr11_-_46312220 | 2.87 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr11_-_69617879 | 2.84 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr8_+_94179089 | 2.82 |
ENSMUST00000034215.6
|
Mt1
|
metallothionein 1 |
chr9_-_21963568 | 2.81 |
ENSMUST00000006397.5
|
Epor
|
erythropoietin receptor |
chr17_-_6782775 | 2.80 |
ENSMUST00000064234.6
|
Ezr
|
ezrin |
chr3_-_132950043 | 2.80 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chr4_+_155962292 | 2.79 |
ENSMUST00000024338.4
|
Fam132a
|
family with sequence similarity 132, member A |
chr2_+_91035613 | 2.76 |
ENSMUST00000111445.3
ENSMUST00000111446.3 ENSMUST00000050323.5 |
Rapsn
|
receptor-associated protein of the synapse |
chr3_+_10012548 | 2.76 |
ENSMUST00000029046.8
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr14_+_70457447 | 2.76 |
ENSMUST00000003561.3
|
Phyhip
|
phytanoyl-CoA hydroxylase interacting protein |
chr6_-_115758974 | 2.74 |
ENSMUST00000072933.6
|
Tmem40
|
transmembrane protein 40 |
chr7_-_44532064 | 2.73 |
ENSMUST00000098483.2
ENSMUST00000035323.4 |
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr11_-_72411695 | 2.73 |
ENSMUST00000108500.1
ENSMUST00000050226.6 |
Smtnl2
|
smoothelin-like 2 |
chr1_+_135799833 | 2.73 |
ENSMUST00000148201.1
|
Tnni1
|
troponin I, skeletal, slow 1 |
chr6_+_71707561 | 2.69 |
ENSMUST00000121469.1
|
Reep1
|
receptor accessory protein 1 |
chr17_-_7352696 | 2.68 |
ENSMUST00000115747.1
|
Ttll2
|
tubulin tyrosine ligase-like family, member 2 |
chr4_-_127330799 | 2.68 |
ENSMUST00000046532.3
|
Gjb3
|
gap junction protein, beta 3 |
chr1_+_134182404 | 2.68 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chrX_-_162964557 | 2.68 |
ENSMUST00000038769.2
|
S100g
|
S100 calcium binding protein G |
chr13_+_45507438 | 2.66 |
ENSMUST00000000260.6
|
Gmpr
|
guanosine monophosphate reductase |
chr17_+_5799491 | 2.65 |
ENSMUST00000181484.1
|
3300005D01Rik
|
RIKEN cDNA 3300005D01 gene |
chr17_-_26199008 | 2.65 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr7_+_143005638 | 2.65 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
Tspan32
|
tetraspanin 32 |
chr1_-_90153396 | 2.63 |
ENSMUST00000113094.2
|
Iqca
|
IQ motif containing with AAA domain |
chr16_-_18621366 | 2.62 |
ENSMUST00000051160.2
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr4_+_44300876 | 2.62 |
ENSMUST00000045607.5
|
Melk
|
maternal embryonic leucine zipper kinase |
chr2_+_79255500 | 2.61 |
ENSMUST00000099972.4
|
Itga4
|
integrin alpha 4 |
chr4_-_41048124 | 2.60 |
ENSMUST00000030136.6
|
Aqp7
|
aquaporin 7 |
chr4_+_49059256 | 2.59 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr15_-_89425856 | 2.59 |
ENSMUST00000109313.2
|
Cpt1b
|
carnitine palmitoyltransferase 1b, muscle |
chr7_+_143005677 | 2.57 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
Tspan32
|
tetraspanin 32 |
chr7_-_25615874 | 2.55 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
chr11_-_69900949 | 2.55 |
ENSMUST00000102580.3
|
2810408A11Rik
|
RIKEN cDNA 2810408A11 gene |
chr3_+_68869563 | 2.54 |
ENSMUST00000054551.2
|
1110032F04Rik
|
RIKEN cDNA 1110032F04 gene |
chr9_+_58014990 | 2.54 |
ENSMUST00000034874.7
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1 |
chr13_-_37049203 | 2.53 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr7_-_139992544 | 2.51 |
ENSMUST00000026546.9
ENSMUST00000106069.2 ENSMUST00000148670.1 |
Adam8
|
a disintegrin and metallopeptidase domain 8 |
chr2_+_84840612 | 2.51 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr5_+_90768511 | 2.50 |
ENSMUST00000031319.6
|
Ppbp
|
pro-platelet basic protein |
chr5_-_145584723 | 2.49 |
ENSMUST00000075837.6
|
Cyp3a41b
|
cytochrome P450, family 3, subfamily a, polypeptide 41B |
chr1_-_52953179 | 2.49 |
ENSMUST00000114492.1
|
1700019D03Rik
|
RIKEN cDNA 1700019D03 gene |
chr9_-_44288131 | 2.49 |
ENSMUST00000160384.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr2_-_157007039 | 2.49 |
ENSMUST00000103129.2
ENSMUST00000103130.1 |
Dsn1
|
DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) |
chr18_-_78142119 | 2.48 |
ENSMUST00000160639.1
|
Slc14a1
|
solute carrier family 14 (urea transporter), member 1 |
chr17_-_35702040 | 2.47 |
ENSMUST00000166980.2
ENSMUST00000145900.1 |
Ddr1
|
discoidin domain receptor family, member 1 |
chr1_+_135799402 | 2.47 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chr7_+_128062657 | 2.46 |
ENSMUST00000120355.1
ENSMUST00000106240.2 ENSMUST00000098015.3 |
Itgam
|
integrin alpha M |
chr6_-_136781718 | 2.45 |
ENSMUST00000078095.6
ENSMUST00000032338.7 |
Gucy2c
|
guanylate cyclase 2c |
chr11_+_120948480 | 2.45 |
ENSMUST00000070653.6
|
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr15_-_75111684 | 2.42 |
ENSMUST00000100542.3
|
Ly6c2
|
lymphocyte antigen 6 complex, locus C2 |
chr4_+_41569775 | 2.42 |
ENSMUST00000102963.3
|
Dnaic1
|
dynein, axonemal, intermediate chain 1 |
chr5_+_122100951 | 2.42 |
ENSMUST00000014080.6
ENSMUST00000111750.1 ENSMUST00000139213.1 ENSMUST00000111751.1 ENSMUST00000155612.1 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr1_-_119422239 | 2.42 |
ENSMUST00000038765.5
|
Inhbb
|
inhibin beta-B |
chr15_-_103255433 | 2.41 |
ENSMUST00000075192.6
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr5_-_113800356 | 2.41 |
ENSMUST00000160374.1
ENSMUST00000067853.5 |
Tmem119
|
transmembrane protein 119 |
chr17_-_35702297 | 2.41 |
ENSMUST00000135078.1
|
Ddr1
|
discoidin domain receptor family, member 1 |
chr2_-_32387760 | 2.40 |
ENSMUST00000050785.8
|
Lcn2
|
lipocalin 2 |
chr7_-_14123042 | 2.40 |
ENSMUST00000098809.2
|
Sult2a3
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 3 |
chr8_-_123859423 | 2.38 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr17_+_55952623 | 2.37 |
ENSMUST00000003274.6
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chr17_+_47726834 | 2.36 |
ENSMUST00000024782.5
ENSMUST00000144955.1 |
Pgc
|
progastricsin (pepsinogen C) |
chr4_+_121039385 | 2.35 |
ENSMUST00000030372.5
|
Col9a2
|
collagen, type IX, alpha 2 |
chr14_-_69284982 | 2.35 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr7_-_3677509 | 2.34 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr2_+_103969528 | 2.34 |
ENSMUST00000123437.1
ENSMUST00000163256.1 |
Lmo2
|
LIM domain only 2 |
chr9_+_51213683 | 2.31 |
ENSMUST00000034554.7
|
Pou2af1
|
POU domain, class 2, associating factor 1 |
chr11_-_94474088 | 2.30 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr3_-_54915867 | 2.29 |
ENSMUST00000070342.3
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr17_+_31208049 | 2.28 |
ENSMUST00000173776.1
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr14_-_30915387 | 2.28 |
ENSMUST00000166622.1
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr7_-_45920830 | 2.27 |
ENSMUST00000164119.1
|
Emp3
|
epithelial membrane protein 3 |
chr5_+_135023482 | 2.27 |
ENSMUST00000005509.4
|
Stx1a
|
syntaxin 1A (brain) |
chr13_+_73467197 | 2.26 |
ENSMUST00000022099.8
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr11_-_98053415 | 2.26 |
ENSMUST00000017544.2
|
Stac2
|
SH3 and cysteine rich domain 2 |
chr2_-_165388245 | 2.26 |
ENSMUST00000103084.3
|
Zfp334
|
zinc finger protein 334 |
chr17_-_29237759 | 2.26 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chr12_-_114416895 | 2.26 |
ENSMUST00000179796.1
|
Ighv6-5
|
immunoglobulin heavy variable V6-5 |
chr6_-_128355826 | 2.25 |
ENSMUST00000001562.6
|
Tulp3
|
tubby-like protein 3 |
chr15_+_99074968 | 2.25 |
ENSMUST00000039665.6
|
Troap
|
trophinin associated protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:0002215 | defense response to nematode(GO:0002215) |
3.5 | 10.5 | GO:0030221 | basophil differentiation(GO:0030221) |
2.6 | 7.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.4 | 7.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.0 | 10.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.0 | 3.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.9 | 7.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.4 | 5.7 | GO:1902896 | terminal web assembly(GO:1902896) |
1.4 | 14.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 4.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.3 | 6.3 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.3 | 2.5 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
1.3 | 2.5 | GO:0051885 | positive regulation of anagen(GO:0051885) |
1.2 | 10.7 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
1.2 | 8.1 | GO:0015840 | urea transport(GO:0015840) |
1.2 | 3.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.1 | 3.4 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
1.1 | 3.3 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 4.4 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.1 | 4.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 8.7 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 6.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
1.1 | 4.2 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
1.0 | 4.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 6.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.0 | 3.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.0 | 3.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.0 | 4.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.0 | 3.8 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.9 | 15.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.9 | 0.9 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.9 | 7.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.9 | 4.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 2.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.8 | 5.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 2.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.8 | 1.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.8 | 4.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.8 | 0.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.7 | 2.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 2.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.7 | 10.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.7 | 3.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 4.3 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 7.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 6.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.7 | 5.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 2.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.7 | 1.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.7 | 1.4 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.7 | 2.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.7 | 2.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 3.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 2.7 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.7 | 3.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.6 | 10.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 2.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.6 | 2.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.6 | 1.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.6 | 2.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.6 | 2.4 | GO:0060279 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) positive regulation of ovulation(GO:0060279) |
0.6 | 3.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 23.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 3.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 3.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 4.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 1.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 1.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 6.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.6 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.5 | 2.2 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.5 | 1.1 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.5 | 0.5 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.5 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.5 | 1.6 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.5 | 2.1 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 1.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.5 | 2.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 3.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 3.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 2.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 3.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.5 | 4.5 | GO:0031179 | peptide modification(GO:0031179) |
0.5 | 1.5 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.5 | 2.0 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.5 | 2.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.5 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.5 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 4.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 0.5 | GO:0035854 | eosinophil fate commitment(GO:0035854) |
0.5 | 4.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 1.0 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.5 | 2.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 1.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.5 | 4.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 1.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.9 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.5 | 1.4 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.5 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 2.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 2.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.4 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.4 | 8.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.9 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 2.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.4 | 1.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 2.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 5.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 | 1.3 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 0.8 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.4 | 1.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 1.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 0.4 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.4 | 2.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 1.5 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.4 | 1.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 1.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.4 | 1.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 1.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 1.5 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.4 | 1.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 13.9 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 1.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.7 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 1.4 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.4 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.4 | 0.7 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.3 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 1.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 2.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 2.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 9.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 1.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 1.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 3.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.3 | 1.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 2.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 2.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 2.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 6.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 1.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.6 | GO:0036166 | phenotypic switching(GO:0036166) |
0.3 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 3.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.9 | GO:0061076 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.3 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 2.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 0.6 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.3 | 1.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.3 | 2.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 3.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.1 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 2.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 1.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.5 | GO:0035481 | Notch signaling pathway involved in heart induction(GO:0003137) regulation of Notch signaling pathway involved in heart induction(GO:0035480) positive regulation of Notch signaling pathway involved in heart induction(GO:0035481) |
0.3 | 1.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 0.8 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.3 | 1.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 0.5 | GO:0015675 | nickel cation transport(GO:0015675) |
0.3 | 0.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 3.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 2.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 1.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 2.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 1.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 1.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.7 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.2 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.7 | GO:2000387 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
0.2 | 0.9 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 1.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.2 | 5.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 1.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 2.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 3.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.2 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.9 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.2 | 0.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.9 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.2 | 1.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.7 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 3.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.4 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 3.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.4 | GO:0002554 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 1.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 2.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.8 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 2.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 0.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.6 | GO:2000389 | neutrophil extravasation(GO:0072672) regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.2 | 1.0 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 2.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.8 | GO:0033368 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 1.0 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.2 | 6.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.2 | 2.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.4 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 1.9 | GO:0015810 | aspartate transport(GO:0015810) |
0.2 | 1.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.2 | 0.9 | GO:0032901 | regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.2 | 1.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.4 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.2 | 2.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 1.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 1.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 1.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.8 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 2.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 3.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) GTP biosynthetic process(GO:0006183) |
0.2 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.5 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 3.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 3.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 3.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 1.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 1.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.3 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 3.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.9 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 1.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.6 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:2000321 | negative regulation of interleukin-1 beta secretion(GO:0050713) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 1.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 1.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.5 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 6.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 4.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 3.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.1 | 3.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 2.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.1 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 4.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.2 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.8 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 2.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 7.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 1.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.4 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 9.9 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 2.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 2.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 2.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 10.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.1 | 1.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 1.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.8 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.4 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 2.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.3 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.7 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 1.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 2.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.5 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 5.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.8 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 5.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 2.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.5 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 3.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 2.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.7 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 1.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.5 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 1.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 1.4 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.2 | GO:0042697 | menopause(GO:0042697) |
0.1 | 0.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.1 | GO:0061193 | stem cell fate commitment(GO:0048865) taste bud development(GO:0061193) |
0.1 | 0.2 | GO:0086064 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.9 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.0 | 1.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.0 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 3.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.6 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.0 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.7 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.0 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 1.9 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 1.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.0 | 0.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 1.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 1.4 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.3 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 1.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 2.4 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.0 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 1.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.2 | GO:0050716 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.5 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.2 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.6 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.6 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.0 | 0.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.0 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0015881 | creatine transport(GO:0015881) |
0.0 | 0.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 7.3 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.2 | 22.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.2 | 4.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.0 | 3.1 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.0 | 3.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.0 | 4.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 16.8 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 2.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.8 | 2.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.8 | 2.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.8 | 4.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 10.3 | GO:0042581 | specific granule(GO:0042581) |
0.7 | 2.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.7 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 4.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.6 | 3.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 2.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 2.6 | GO:0071914 | prominosome(GO:0071914) |
0.5 | 5.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 4.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 9.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 11.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 2.3 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 3.0 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.3 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.4 | 6.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 2.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 3.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 4.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.4 | 2.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 5.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 2.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 2.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 1.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 2.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.3 | 1.4 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 8.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 4.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 7.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 3.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 3.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 2.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 2.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 0.8 | GO:0036019 | endolysosome(GO:0036019) |
0.3 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 2.1 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 7.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 5.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 4.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.2 | 6.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 4.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 4.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.8 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 7.5 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 2.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 6.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 4.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 6.1 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 4.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 3.3 | GO:0031430 | M band(GO:0031430) |
0.2 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.2 | 1.0 | GO:0031673 | H zone(GO:0031673) |
0.2 | 2.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 2.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 16.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.8 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 2.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 5.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 5.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 2.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 2.1 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 3.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 12.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 5.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 1.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 3.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.3 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 3.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 13.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 7.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 7.4 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 2.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 3.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 8.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 9.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 5.0 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 2.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
0.0 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 3.9 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 5.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 11.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 1.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.0 | 19.6 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 7.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 1.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.5 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.2 | 2.5 | GO:0015265 | urea channel activity(GO:0015265) |
1.1 | 1.1 | GO:0070401 | NADP+ binding(GO:0070401) |
1.1 | 3.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.1 | 4.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.0 | 25.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 5.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 3.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.0 | 3.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 9.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 6.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 3.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 3.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.9 | 8.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.9 | 0.9 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.9 | 4.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.8 | 5.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.8 | 3.8 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.8 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 2.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 2.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 2.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.7 | 2.1 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.7 | 3.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 3.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 6.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 2.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 2.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 2.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 3.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.6 | 2.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.6 | 6.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.6 | 3.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 8.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 4.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.5 | 1.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 2.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 3.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 2.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 2.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 4.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 1.4 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.5 | 1.4 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.4 | 2.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 8.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 3.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 3.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 1.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 2.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.4 | 2.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 2.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 7.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 1.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 7.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 1.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.8 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 7.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.1 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.4 | 1.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 1.8 | GO:0055056 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 2.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 2.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 2.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 3.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.6 | GO:0043532 | angiostatin binding(GO:0043532) |
0.3 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 2.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 4.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 1.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.3 | 1.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 3.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.6 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.3 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 0.8 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 6.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 3.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 9.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 8.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 2.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 2.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 2.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 9.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 3.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 0.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 1.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.5 | GO:0015099 | cobalt ion transmembrane transporter activity(GO:0015087) nickel cation transmembrane transporter activity(GO:0015099) |
0.3 | 8.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 8.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 2.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 5.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 4.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 1.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 6.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 1.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 2.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 5.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 1.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 2.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 1.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.6 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 8.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.6 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.6 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.2 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 3.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 10.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 2.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.6 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 10.1 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.9 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.8 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 0.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 2.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 1.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.5 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.2 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.3 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.6 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.1 | 1.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 2.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 8.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 1.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 3.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 6.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 4.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 3.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 3.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 2.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 1.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 3.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:1901338 | catecholamine binding(GO:1901338) |
0.1 | 2.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 7.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 1.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.7 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.1 | 2.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 1.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.4 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 2.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 4.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 8.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 2.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 7.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 2.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 14.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 4.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 1.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 6.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 5.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 0.1 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 1.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 5.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.3 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 1.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 7.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 1.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 1.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 6.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 2.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) SUMO conjugating enzyme activity(GO:0061656) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.0 | 0.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 8.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 5.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.1 | 8.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 8.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 0.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 1.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 14.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 1.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 5.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 15.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 3.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 7.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 4.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 2.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 8.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 25.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 10.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 1.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 11.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.7 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 2.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 6.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 4.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 5.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 6.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 5.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 4.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 17.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 3.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 11.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 5.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 3.5 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 10.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 28.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 6.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 3.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 4.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 5.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 3.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 3.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 4.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 6.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 8.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 4.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 9.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 10.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 7.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 9.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 2.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 2.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 4.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 10.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 3.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 7.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 18.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 2.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 6.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 0.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 9.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 3.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 3.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 2.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 2.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 3.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 3.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 4.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 9.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 5.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 5.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 4.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 4.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 4.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |